Numerous mutations in the carboxyl half of the protein are associated with the development of cardiomyopathies further confirming the importance of the C terminal domains of cTnI for proper regulation of cardiac contraction (Chang et al., 2008; Tachampa et al., 2008). The gene discussed is TNNI3; the disease is cardiomyopathy.